Hawai‘i State Department of Health
Department of Health HAWAII.GOV  
Stay Connected to Hawaii State Government
Search:
February 13, 2002

Hawaii Statewide Syringe Exchange Program

Evaluation Report Results

On Thursday, February 14, 2002, from 3:00 PM to 5:00 PM at the Department of Health, Kinau Hale first floor boardroom, Don Des Jarlais, Ph.D. will present the 2001 Evaluation Report of the Hawaii Statewide Syringe Exchange Program. Dr. Des Jarlais will be available between 1:00 PM and 2:00 PM that day for media interviews at the Department of Health’s Kinau Hale Boardroom, or can be reached during that hour at 586-4580.

Dr. Des Jarlais is the Director of Research at the Chemical Dependency Institute at Beth Israel Medical Center in New York City and is world renown for his work and expertise in the field of HIV prevention and Syringe Exchange Programs. He serves as a consultant to the U.S. Centers for Disease Control and Prevention, the U. S. National Institutes of Health, and the World Health Organization. He is currently the Coordinator for the World Health Organization Multi-Site Study Survey of HIV and Drug Use. This study is being implemented in 14 different sites worldwide.

Dr. Des Jarlais has found that nationally there is a resurgence of HIV infection among men who have sex with men, and that new cases of HIV related to drug injection are leading the epidemic. Globally, the HIV crisis worsens, particularly in developing countries.

In this time of heightened concern about the direction of the HIV/AIDS pandemic, Hawaii has demonstrated leadership in this area of public health. The statewide Syringe Exchange Program provides a national model for reducing injection related HIV transmission. The Program has increased the number of syringes exchanged each year since 1996. All available data reflect very low levels of injection related HIV infection in the state.

The Syringe Exchange Program has developed innovative methods of reaching drug users, which have proven very effective. An increase in the number of program participants reporting injection of methamphetamine from 6% two years ago to 28% this year calls for continued vigilance against the passing of blood-borne disease through the sharing of injection equipment.

# # #